Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine signaling pathway is not a single molecular target but rather a form of cell-to-cell communication in which one cell produces signals—such as growth factors, cytokines, or neurotransmitters—that diffuse over short distances to induce changes in nearby cells. These paracrine factors bind to specific receptors on adjacent cells and trigger intracellular signal transduction cascades that alter gene expression and cellular behavior. This type of signaling is essential for processes such as tissue patterning during development, immune system activation, inflammation regulation, tissue repair, and maintenance of homeostasis. The effects are typically rapid and localized because the released molecules are quickly degraded or taken up by neighboring cells to prevent widespread action. Major families of paracrine pathways include those mediated by fibroblast growth factor (FGF), Hedgehog proteins (e.g., Sonic hedgehog), Wnt proteins, and TGF-beta superfamily members; these often act through conserved receptor types like receptor tyrosine kinases or G-protein coupled receptors[1][2][5]. Note: "Paracrine signaling pathway" refers to a class/mechanism of intercellular communication rather than an individual druggable target such as a receptor or enzyme. It cannot be directly targeted by drugs in the same way as specific molecules; instead, drugs may modulate components within these pathways (e.g., FGF receptors). Therefore: — It is not considered a therapeutic target itself. — There are no direct interacting drugs. — There are no direct biomarkers or safety concerns associated with "paracrine signaling pathway" per se. If you need information about specific molecular targets within paracrine pathways—for example "Fibroblast growth factor receptor 1"—please specify the molecule/receptor name for structured data extraction[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling pathway (null).